The Net Margin of Royalty Pharma PLC (RPRX) is 37.95%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 37.95% |
| 2023-12-31 | 48.20% |
| 2022-12-31 | 1.91% |
| 2021-12-31 | 27.07% |
| 2020-12-31 | 45.94% |
| 2019-12-31 | 129.44% |
| 2018-12-31 | 76.76% |
| 2017-12-31 | 75.72% |